Literature DB >> 2939001

[Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].

J F Bergmann, P Rougier, C Liguory, E S Zafrani, J M Métreau, D Dhumeaux.   

Abstract

A case of sclerosing cholangitis after a two-month treatment by hepatic artery infusion of FUDR is reported. The patient presented with jaundice and a marked increase in serum alkaline phosphatase activity which persisted after withdrawal of FUDR infusion. Endoscopic retrograde cholangiogram revealed a stricture of the middle part of the common bile duct, which was treated by endoprosthesis insertion. From this report, as well as those previously published, it is concluded that sclerosing cholangitis may complicate continuous hepatic artery infusion with FUDR. This lesion could be secondary to an FUDR-induced arteritis in the branches of hepatic artery which supply bile ducts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939001

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  1 in total

1.  [Animal experiment studies of the toxicity of fluorodeoxyuridine (FUDR) and 5-fluorouracil (FU) within the scope of regional liver infusion chemotherapy].

Authors:  P Schlag; J Yi; P Friedl; W Hull; M Berger
Journal:  Langenbecks Arch Chir       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.